History

 

August 15, 2012Established; Taka-Aki Sato appointed as President and CEO
August 15, 2012Certified as a spin-off venture of the University of Tsukuba
January 2017University of Tsukuba establishes “Research and Development Center for Precision Medicine” Taka-aki Sato serves as Director
October 2017Next-Generation Sequencing service launch
October 2019Registered as a Clinical Laboratory; begins offering Precision-Exome Testing in collaboration with Keio University Hospital and other institutions.
January 2020Capital and business alliance formed with ITOCHU Corporation
March 2020Capital and business alliance formed with Shimadzu Corporation
September 2020Metabolite analysis service Launch
January 2021Genome information value exchange service patent registration (Patent No. 6980240)
March 2021Genomic screening starts in collaboration with the University of Tsukuba Hospital and others
June 2022Long-read sequencing service launched
March 2023Series A funding
September 2023Methylation analysis service launched
February 2024Special analysis service launch
May 2024Launched genetic expression testing in collaboration with Ginza Clinic.
March 2025Series B funding
July 2025Extended series B funding round